Full Text View
Tabular View
No Study Results Posted
Related Studies
Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study (MIND)
This study is not yet open for participant recruitment.
Study NCT00649961   Information provided by Imperial College London
First Received: March 27, 2008   Last Updated: March 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Premature Birth
Brain Injury
Additional conditions recognized in this trial
Brain Injuries
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Craniocerebral Trauma
Disorders of Environmental Origin
Nervous System Diseases
Obstetric Labor Complications
Obstetric Labor, Premature
Pregnancy Complications
Trauma, Nervous System
Wounds and Injuries
Interventions listed in this trial
Melatonin injection
Additional drug interventions recognized in this trial
Melatonin
Neuroprotective Agents
More general drug interventions related to this trial
Antioxidants
Central Nervous System Agents
Central Nervous System Depressants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Imperial College London
British Medical Research Council


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services